Issues related to the experimental design and subsequent statistical analysis of in vivo and in vitro comet studies

Author(s):  
D.P. Lovell ◽  
G. Thomas ◽  
R. Dubow
2020 ◽  
Vol 17 (3) ◽  
pp. 207-217
Author(s):  
Eman A. Hakeem ◽  
Galal M. El-Mahrouk ◽  
Ghada Abdelbary ◽  
Mahmoud H. Teaima

Background: Clopidogrel (CLP) suffers from extensive first pass metabolism results in a negative impact on its oral systemic bioavailability. Cubosomes are Lyotropic Liquid Crystalline (LLC) nano-systems comprising monoolein, a steric stabilizer and an aqueous system, it considered a promising carrier for different pharmaceutical compounds. Box-Behnken Design (BBD) is an efficient tool for process analysis and optimization skipping forceful treatment combinations. Objective: The study was designed to develop freeze-dried clopidogrel loaded LLC (cubosomes) for enhancement of its oral bioavailability. Methods: A 33 BBD was adopted, the studied independent factors were glyceryl monooleate (GMO lipid phase), Pluronic F127 (PL F127steric stabilizer) and polyvinyl alcohol powder (stabilizer). Particle Size (PS), Polydispersity Index (PDI) and Zeta Potential (ZP) were set as independent response variables. Seventeen formulae were prepared in accordance with the bottom up approach and in-vitro evaluated regarding PS, PDI and ZP. Statistical analysis and optimization were achieved using design expert software®, then the optimum suggested formula was prepared, in-vitro revaluated, freeze-dried with 3% mannitol (cryoprotectant), solid state characterized and finally packed in hard gelatin capsule for comparative in-vitro release and in-vivo evaluation to Plavix®. Results: Results of statistical analysis of each individual response revealed a quadratic model for PS and PDI where a linear model for ZP. The optimum suggested formula with desirability factor equal 0.990 consisting of (200 mg GMO, 78.15 mg PL F127 and 2% PVA). LC/MS/MS study confirmed significant higher C>max, AUC>0-24h and AUC>0-∞ than that of Plavix®. Conclusion: The results confirm the capability of developed carrier to overcome the low oral bioavailability.


2020 ◽  
pp. 002367722093005
Author(s):  
Maria Stokstad ◽  
Peter Coetzee ◽  
Mette Myrmel ◽  
Paidamwoyo Mutowembwa ◽  
Estelle H Venter ◽  
...  

Bluetongue is a serious non-contagious vector-borne viral disease in ruminants, causing poor animal welfare and economic consequences globally. Concern has been raised about the development of novel bluetongue virus (BTV) strains and their possibly altered virulence through the process of viral reassortment. Virulence is traditionally estimated in lethal dose 50 (LD50) studies in murine models, but agreement with both in vitro and virulence in ruminants is questionable, and a refined experimental design is needed. Specific reassortants between wild-type and vaccine strains of BTV-1, -6 and -8 have previously been developed by reverse genetics. The aim of the present study was to rank the in vivo virulence of these parental and reassortant BTV strains by calculating LD50 in a murine model by using an experimental design that is new to virology: a between-patient optimised three-level response surface pathway design. The inoculation procedure was intracranial. Fifteen suckling mice were used to establish LD50 for each strain. Three parental and five reassortant virus strains were included. The LD50s varied from of 0.1 (95% confidence interval (CI) 0–0.20) to 3.3 (95% CI 2.96–3.72) tissue culture infectious dose 50/ml. The results support the hypothesis that reassortment in BTV may lead to increased virulence in mice with potential negative consequences for the natural ruminant host. The ranking showed low agreement with in vitro properties and virulence in ruminants according to existing literature. Refined design such as response surface pathway design was found suitable for use in virology, and it introduces significant ethical and scientific improvements.


Author(s):  
Rituraj Niranjan ◽  
Muthukumaravel Subramanian ◽  
Devaraju Panneer ◽  
Sanjay Kumar Ojha

Background: Diesel exhaust particulates (DEPs) affect lung physiology and cause serious damage to the lungs. A number of studies demonstrated that, eosinophils play a very important role in the development of tissue remodelling and fibrosis of lungs. However, the exact mechanism of pathogenesis of tissue remodelling and fibrosis is not known. Methods: Both in vitro and in vivo models were used in the study. HL-60 and A549 cells were used in the study. Balb/C mice of 8 to 12 weeks old were used for in vivo study. Cell viability by MTT assay, RNA isolation by tri reagent was accomplished. mRNA expression of inflammatory genes were accomplished by real time PCR or qPCR. Immunohistochemistry was done to asses the localization and expressions of proteins. One way ANOVA followed by post hoc test were done for the statistical analysis. Graph-Pad Prism software was used for statistical analysis. Results: We for the first time demonstrate that, Interleukin-13 plays a very important role in the development of tissue remodelling and fibrosis. We report that, diesel exhaust particles significantly induce eosinophils cell proliferation and interleukin-13 release in in vitro culture conditions. Supernatant collected from DEP-induced eosinophils cells significantly restrict cell proliferation of epithelial cells in response to exposure of diesel exhast particles. Furthermore, purified interleukin-13 decreases the proliferation of A549 cells, highliting the involvement of IL-13 in tissue remodeling. Notably, Etoricoxib (selective COX-2 inhibitor) did not inhibit DEP-triggered release of interleukin-13, suggesting another cell signalling pathway. The in vivo exposer of DEP to the lungs of mice, resulted in high level of eosinophils degranulation as depicted by the EPX-1 immunostaining and altered level of mRNA expressions of inflammatory genes. We also found that, a-SMA, fibroblast specific protein (FSP-1) has been changed in response to DEP in the mice lungs along with the mediators of inflammation. Conclusion: Altogether, we elucidated, the mechanistic role of eosinophils and IL-13 in the DEP-triggered proliferation of lungs cells thus providing an inside in the pathophysiology of tissue remodelling and fibrosis of lungs.


2006 ◽  
Vol 18 (2) ◽  
pp. 273
Author(s):  
M. K. Kim ◽  
H. J. Oh ◽  
Y. H. Fibrianto ◽  
G. Jang ◽  
H. J. Kim ◽  
...  

A bitch ovulates a primary oocyte that undergoes both maturation and fertilization within the oviduct fluid for 3 days. In an attempt to define the physiologically appropriate conditions for oocyte maturation in the bitch, in vitro conditions based upon the oviductal environment need to be established. The present study was conducted to develop canine synthetic oviduct fluid (cSOF) by investigating the composition of canine oviduct fluid, follicular fluid, and bursa fluid. The bursa and oviduct fluid were collected at Days 1 and 3 of ovulation, respectively. Before ovulation, follicles were punched and the fluid was collected by aspiration. Biochemical parameters (Ca, P, Mg, albumin, total protein, and glucose) were measured using a chromatographic enzymic method. Quantitative determination of electrolytes (Na, Cl, K) concentration in the follicular, bursa, and oviductal fluids was performed using an Electrolyte 5 Analyzer (Nora Biomedical, Waltham, MA, USA). The concentrations of sodium, potassium, and chloride were similar among oviduct (153.5, 5.2, and 121.5 mmol/L, respectively), bursa (149.5, 4.3, and 123 mmol/L, respectively), and follicular (147, 4.2, and 120.5 mmol/L, respectively) fluids. Glucose concentration was different in oviduct, bursa, and follicular fluids (1.09, 3.75, and 3.94 mmol/L, respectively). Total protein and magnesium concentrations were not different among the three fluids, but phosphorus concentration differed in oviduct, bursa, and follicular fluids (0.001, 0.044, and 0.024 g/L, respectively). The oviduct fluid showed lower concentrations of albumin and calcium (0.001 g/L and 1.372 mmol/L, respectively) compared to bursa (0.023 g/L and 2.532 mmol/L, respectively) or follicular fluid (0.025 g/L and 2.632 mmol/L, respectively). The cSOF1 and cSOF2 were developed on the basis of the oviduct and follicular fluids, respectively. Canine oocytes were recovered by slicing ovaries collected after ovariohysterectomy in bitches at follicular stages, and in vitro nuclear maturation of canine oocytes cultured in cSOF1 or cSOF2 were compared to that of intra-oviduct (in vivo) culture. For in vivo culture, the canine oocytes were transferred and cultured in intra-oviduct for 72 h and were recovered by intra-oviduct flushing using surgical methods. For in vitro culture, canine oocytes were cultured in cSOF1, cSOF2, or TCM-199 (control) for 72 h at 38.5�C in a humidified atmosphere of 5% CO2 in air. The experiment was replicated three times and statistical analysis was carried out by ANOVA with GLMs in the statistical analysis system program (SAS Institute, Inc., Cary, NC, USA). Nuclear maturation of canine oocytes to MII was not different in cSOF1, cSOF2, or intra-oviduct (2.5%, 2.5%, and 2.2%, respectively) compared to the control (1.6%). However, the degeneration rates were significantly higher in oocytes cultured in intra-oviduct (48.2%) compared to control, cSOF1, and cSOF2 (1.6%, 6.8%, and 7.5%, respectively). In conclusion, the present study analyzed the components of the oviduct, bursa, and follicular fluids and developed two canine synthetic oviduct fluids (cSOF1 and 2). In addition, the present study demonstrated that cSOFs can be used for in vitro maturation of canine oocytes.


2018 ◽  
Vol 24 (30) ◽  
pp. 3576-3586
Author(s):  
Sima Singh ◽  
Afzal Hussain ◽  
Uma Ranjan Lal ◽  
Nisar Sayyad ◽  
Rajshekhar Karpoormath ◽  
...  

The present study focused to optimize dual coated multiparticulates using Box-Behnken Experimental Design and in-silico simulation using GastroPlusTM software. The optimized formulations (OB1 and OB2) were comparatively evaluated for particle size, morphological, in vitro drug release, and in vivo permeation studies. In silico simulation study predicted the in vivo performance of the optimized formulation based on in-vitro data. Results suggested that optimized formulation was obtained using maximum content of Eudragit FS30D and minimum drying time (2 min). In vitro data corroborated that curcumin release was completely protected from premature drug release in the proximal part of gastro intestinal tract and successfully released to the colon (95%) which was closely predicted (90.1 %) by GastroPlusTM simulation technique. Finally, confocal laser scanning microscopy confirmed the in-vitro findings wherein maximum intensity was observed with OB1 treated group suggesting successful delivery of OB1 to the colon for enhanced absorption as predicted in regional absorption profile in ascending colon (30.9%) and caecum (23.2%). Limited drug absorption was predicted in small intestine (1.5-8.7%). The successful outcomes of the research work minimized the release of curcumin in the upper gastric tract and the maximized drug access to the colon (pH 7.4) as prime concern.


2015 ◽  
Vol 4 (1_suppl) ◽  
pp. gahmj.2015.013.
Author(s):  
Gloria Gronowicz ◽  
William Bengston ◽  
Garret Yount

Preclinical models for studying the effects of the human biofield have great potential to advance our understanding of human biofield modalities, which include external qigong, Johrei, Reiki, therapeutic touch, healing touch, polarity therapy, pranic healing, and other practices. A short history of Western biofield studies using preclinical models is presented and demonstrates numerous and consistent examples of human biofields significantly affecting biological systems both in vitro and in vivo. Methodological issues arising from these studies and practical solutions in experimental design are presented. Important questions still left unanswered with preclinical models include variable reproducibility, dosing, intentionality of the practitioner, best preclinical systems, and mechanisms. Input from the biofield practitioners in the experimental design is critical to improving experimental outcomes; however, the development of standard criteria for uniformity of practice and for inclusion of multiple practitioners is needed. Research in human biofield studies involving preclinical models promises a better understanding of the mechanisms underlying the efficacy of biofield therapies and will be important in guiding clinical protocols and integrating treatments with conventional medical therapies.


2015 ◽  
Vol 2015 ◽  
pp. 1-11 ◽  
Author(s):  
Rui Cao ◽  
Hong Zhang ◽  
Jie Guo ◽  
Xiao-hui Liu ◽  
Chang Liu ◽  
...  

Objectives. Hua-Zheng-Hui-Sheng-Dan (HZHSD) was used as an experimental model to explore research methods of large formulae in traditional Chinese medicine (TCM) using current molecular biology approaches.Materials and Methods. The trypan blue exclusion assay was used to determine cell viability and cell numbers. Flow cytometry was used to assess cell cycle distribution and apoptosis. The concentration of cyclin D1 was analyzed by enzyme-linked immunosorbent assay. The median effect principle was used in drug combination studies. An orthogonal experimental design was used to estimate the effects of each herb at different concentrations. The HeLa xenograft mouse model was used to compare the antitumor activity of drugs in vivo.Results. Among the 35 herbs that comprise HZHSD, Radix Rehmanniae Preparata (RRP),Caesalpinia sappan(CS),Evodia rutaecarpa(ER), Folium Artemisiae Argyi (FAA),Leonurus japonicusHoutt (LJH), Tumeric (Tu), Radix Paeoniae Alba (RPA), and Trogopterus Dung (TD) effectively inhibited the proliferation of HeLa and SKOV3 cells. Only RRR had an effect on HeLa and SKOV3 cell viability. According to the median effect principle,Angelica sinensis(Oliv.) (AS),Tabanus(Ta), and Pollen Typhae (PT), which were proven to have a significant synergistic inhibitory effect on the proliferation of HeLa cells, were added to the original eight positive herbs. The combination of RPA and AS had a synergistic effect on inducing cell cycle S phase arrest and decreasing intracellular cyclin D1 in HeLa cells. By orthogonal experimental design, LJH and Tu were considered unnecessary herbs. The small formula (SHZHSD) consisted of RPA, AS, RRR, Ta., TD, PT, ER, CS, and FAA and was able to inhibit cell proliferation and induce cell apoptosis. The antitumor effects of HZHSD and SHZHSD were also compared in vivo.Conclusions. Through molecular biology approaches both in vitro and in vivo, research into single drugs, and analysis using the median effect principle and orthogonal experimental design, the small formula (SHZHSD) was determined from the original formula (HZHSD). SHZHSD exhibited superior antitumor activity compared with the original formula both in vitro and in vivo.


Sign in / Sign up

Export Citation Format

Share Document